Viral Excretion Among COVID-19 Omicron Recurrence Patients

NCT05470426 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2022-07-22

No results posted yet for this study

Summary

The study analyzes the viral nucleic acid excretion and its influencing factors of SARS-COV-2 Omicron recurrence patients.

Conditions

  • COVID-19 Recurrence
  • Surface Contamination

Interventions

OTHER

COVID-19 Omicron Recurrence

COVID-19 Omicron Recurrence

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-31
Primary Completion
2023-07-31
Completion
2023-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05470426 on ClinicalTrials.gov